Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
Researchers developed a rehabilitation platform combining virtual reality with targeted sensory nerve stimulation for stroke recovery. A randomized clinical trial published in Nature Medicine showed improvements in arm/hand function and tactile awareness, offering potential for more personalized rehabilitation beyond conventional therapy.
Patients with autoimmune rheumatic diseases (such as lupus and vasculitis) have significantly elevated stroke risk 1.3-2.5 times higher than the general population, often occurring at younger ages due to systemic inflammation and immune-mediated vascular injury. This review synthesizes evidence on stroke pathophysiology, prevention strategies, and post-stroke rehabilitation outcomes specific to rheumatologic populations.
This health economics study analyzed administrative healthcare data from Italian regions to assess direct medical costs for patients with atherosclerotic cardiovascular diseases, including ischemic stroke and transient ischemic attack, along with acute coronary syndrome and peripheral arterial disease. Over a 2-year period, approximately 350,000 patients were hospitalized annually with average direct costs of €7,190 per patient, with hospitalizations comprising nearly 70% of total expenses.
Duke University researchers developed a noninvasive imaging method to visualize the brain's glymphatic system, which removes metabolic waste. The technique enables examination of how this system is altered in conditions like ischemic stroke, aging, and anesthesia, with implications for understanding neurodegenerative diseases.
Early anticoagulation with non-vitamin K oral anticoagulants reduces recurrent ischemic stroke risk in acute ischemic stroke patients with atrial fibrillation, as confirmed by randomized controlled trials and meta-analyses. Safety concerns remain in high-risk subgroups including severe stroke, hemorrhagic transformation, and Asian populations who are underrepresented in clinical trial data.
